Gelonghui April 3rd 丨Lung Shing Financial (01225.HK) announced that in 2022, the Group's consolidated revenue was approximately HK$218 million, an increase of about 1.4% over last year. The increase in consolidated revenue was mainly due to an increase in the medical products and plastic toys business, of which the increase was HK$10.4 million. The Group's gross margin for the current year was about 66.6%, a decrease of about 2.0 percentage points from the previous year's gross margin of about 68.6%. The Group's loss for 2022 was approximately HK$368 million (2021: HK$65.9 million) and losses attributable to company owners for the year were approximately HK$367 million (2021: HK$65.7 million). The increase in loss was mainly due to a confirmed impairment loss of approximately HK$288 million on loans receivable in 2022.
隆成金融(01225.HK)：2022年度拥有人应占亏损3.67亿港元
Lung Shing Financial (01225.HK): Owners' attributable losses of HK$367 million in 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.